[Anaphylaxis and anaphylactic shock]

Rev Alerg Mex. 2007 Mar-Apr;54(2):34-40.
[Article in Spanish]

Abstract

Term anaphylaxis means an immediate hypersensitivity reaction mediated by IgE that produces a clinical syndrome with systemic affection of variable severity. Its prevalence varies according to the habits of each region and of the studied population from 3.2 to 7.6 cases per 100,000 inhabitants per year. Anaphylaxis secondary to the food ingestion accounts for 30-50% of the cases. Some risk factors have been defined, among them the most important are asthma, food allergy and previous reactions to the same food. Biphasic anaphylactic reactions are those presenting a recurrence of anaphylactic symptoms, after the initial remission of them. Success of treatment is based on the early recognition of signs and symptoms and the instauration of treatment with adrenaline.

Publication types

  • Review

MeSH terms

  • Allergens / adverse effects
  • Anaphylaxis* / diagnosis
  • Anaphylaxis* / drug therapy
  • Anaphylaxis* / epidemiology
  • Anaphylaxis* / immunology
  • Anaphylaxis* / physiopathology
  • Atropine / therapeutic use
  • Chemotactic Factors / metabolism
  • Cytokines / metabolism
  • Drug Therapy, Combination
  • Epinephrine / therapeutic use
  • Fluid Therapy
  • Histamine H1 Antagonists / therapeutic use
  • Histamine Release
  • Humans
  • Immunoglobulin E / immunology
  • Mast Cells / metabolism
  • Methylprednisolone / therapeutic use
  • Prevalence
  • Prostaglandin D2 / metabolism
  • Risk Factors
  • Thrombophilia / etiology
  • Tryptases / metabolism
  • Vasoconstrictor Agents / therapeutic use

Substances

  • Allergens
  • Chemotactic Factors
  • Cytokines
  • Histamine H1 Antagonists
  • Vasoconstrictor Agents
  • Immunoglobulin E
  • Atropine
  • Tryptases
  • Prostaglandin D2
  • Methylprednisolone
  • Epinephrine